Table 4.
Univariate Cox regression |
Multivariate Cox regression |
|||||||
---|---|---|---|---|---|---|---|---|
Variables | P-value | HR | 95% CI | P-value | HR | 95% CI | ||
Risk score (high/low) | 0.02 | 7.11 | 1.42 | 35.54 | 0.01 | 4.08 | 1.43 | 11.68 |
Age (>60/≤60) | 0.02 | 7.34 | 1.3 | 41.57 | 0.03 | 2.86 | 1.09 | 7.56 |
BMI | 0.21 | |||||||
<25 | Reference | |||||||
≥25 | 0.48 | 0.07 | 3.13 | |||||
Not reported | 25.56 | 0.37 | 1750.1 | |||||
Race | 0.26 | |||||||
Non-Asian | Reference | |||||||
Asian | 0.25 | 0.05 | 1.31 | |||||
AFP | 0.34 | |||||||
≤20ng/mL | Reference | |||||||
>20ng/ml | 2.8 | 0.66 | 11.81 | |||||
Not reported | 0.44 | 0.01 | 15.3 | |||||
Gender(Male/Female) | 0.44 | 2.15 | 0.3 | 15.11 | ||||
Hepatitis B or C | 0.1 | |||||||
No | Reference | |||||||
Yes | 0.17 | 0.03 | 0.87 | |||||
Not reported | 0.28 | 0.01 | 10.28 | |||||
Alcohol consumption | ||||||||
No | 0.12 | Reference | ||||||
Yes | 0.12 | 0.01 | 1.74 | |||||
Histologic grade | 0.06 | |||||||
G1-2 | Reference | |||||||
G3-4 | 9.6 | 1.49 | 61.93 | |||||
New tumor event | 0.79 | 0.69 | 0.05 | 10.32 | ||||
Pathologic stage* | 0.7 | |||||||
Stage I+II | Reference | |||||||
Stage III+IV | 2.3 | 0.33 | 16.02 | |||||
Cancer status | 0.37 | |||||||
Tumor free | Reference | |||||||
With tumor | 2.11 | 0.12 | 35.83 | |||||
Not reported | 0.11 | 0 | 8.67 | |||||
Family cancer history | 0.25 | |||||||
No | Reference | |||||||
Yes | 3.11 | 0.46 | 20.93 | |||||
Not reported | 8.42 | 0.48 | 147.11 | |||||
Residual tumor | 0.7 | |||||||
R0 | 0.66 | 0.08 | 5.71 | |||||
Vascular invasion | 0.21 | |||||||
Negative | Reference | |||||||
Positive | 3.61 | 0.87 | 14.91 |
BMI, Body mass index; AFP, Alpha fetoprotein; HR, Hazard ratio; CI, Confidence interval; *TNM staging systems.